Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932035 · ClinicalTrials.gov registry record · Phase 1
Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer
A Phase 1 study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00932035 is a Phase 1 study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 39 participants.
The verdict
NCT00932035, a Phase 1 study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This pilot phase I and randomized phase II trial studies the best way to perform axillary lymph node preservation surgery and to see how well it works in preventing lymphedema in patients with breast cancer. Lymph node mapping may help in planning surgery to remove breast cancer and affected lymph nodes. It is not yet known whether reverse mapping guided axillary lymph node dissection is more effective than standard axillary lymph node dissection in preventing lymphedema.
Interventions
- PROCEDURE quality-of-life assessment
- OTHER Questionnaire administration
- PROCEDURE axillary lymph node dissection
- DRUG isosulfan blue based lymphatic mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932035
The ClinicalTrials.gov registry entry for NCT00932035 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which quality-of-life assessment is the first listed.
NCT00932035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00932035 about?
NCT00932035 is a clinical study titled "Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer". This pilot phase I and randomized phase II trial studies the best way to perform axillary lymph node preservation surgery and to see how well it works in preventing lymphedema in patients with breast cancer. Lymph node mapping may help in planning surgery to remove breast cancer and affected lymph n...
What is the current status of trial NCT00932035?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00932035?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), Questionnaire administration (OTHER), axillary lymph node dissection (PROCEDURE), isosulfan blue based lymphatic mapping (DRUG).
Who is sponsoring clinical trial NCT00932035?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.